| P50 | author | You-Sheng Liang | Q124652617 |
| | Jian-Rong Dai | Q124661555 |
| P2093 | author name string | Wei Wang | |
| | Yuan Ji | |
| | Hong-Jun Li | |
| | Guo-Li Qu | |
| | Tian-Yu Li | |
| | Yi-Li Qian | |
| P2860 | cites work | Efficacy of praziquantel and artemisinin derivatives for the treatment and prevention of human schistosomiasis: a systematic review and meta-analysis | Q21198915 |
| | Systematic review and meta-analysis of artemisinin based therapies for the treatment and prevention of schistosomiasis | Q21560762 |
| | A double-blind field trial on the effects of artemether on Schistosoma japonicum infection in a highly endemic focus in southern China | Q22061952 |
| | Development of antischistosomal drugs in China, with particular consideration to praziquantel and the artemisinins | Q22061953 |
| | Reduced susceptibility to praziquantel among naturally occurring Kenyan isolates of Schistosoma mansoni | Q28475935 |
| | Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk | Q29547716 |
| | The future of artemisinins: natural, synthetic or recombinant? | Q33393892 |
| | Schistosomiasis control in China: the impact of a 10-year World Bank Loan Project (1992-2001). | Q33448779 |
| | Important helminth infections in Southeast Asia diversity, potential for control and prospects for elimination | Q33630928 |
| | Schistosomiasis japonica control and research needs | Q33630932 |
| | Epidemiology of schistosomiasis in the People's Republic of China, 2004. | Q33776658 |
| | The prophylactic effects of artemether against Schistosoma japonicum infections | Q33846496 |
| | Towards an understanding of the mechanism of action of praziquantel | Q33914691 |
| | Research and development of antischistosomal drugs in the People's Republic of China a 60-year review | Q34125799 |
| | Recent investigations of artemether, a novel agent for the prevention of schistosomiasis japonica, mansoni and haematobia | Q34129324 |
| | [Studies on resistance of Schistosoma to praziquantel XIV experimental comparison of susceptibility to praziquantel between PZQ-resistant isolates and PZQ-susceptible isolates of Schistosoma japonicum in stages of adult worms, miracidia and cercaria | Q34179838 |
| | The discovery of artemisinin (qinghaosu) and gifts from Chinese medicine | Q34223139 |
| | The biochemical basis of anthelmintic action and resistance | Q34278624 |
| | Studies on prophylactic effect of artesunate on schistosomiasis japonica | Q73636347 |
| | Achievements of schistosomiasis control in China | Q78501245 |
| | [Field application of oral artesunate for preventing Schistosoma japonicum infection] | Q78875252 |
| | Control of schistosomiasis in China | Q81123467 |
| | Surveillance for schistosomiasis japonica in China from 2000 to 2003 | Q81305301 |
| | [Studies on resistance of Schistosoma to praziquantel XIII resistance of Schistosoma japonicum to praziquantel is experimentally induced in laboratory] | Q83545264 |
| | Schistosomiasis elimination | Q84003458 |
| | The potential of artemether for the control of schistosomiasis | Q34455017 |
| | Artemisinin: mechanisms of action, resistance and toxicity | Q34999485 |
| | Resistance of Schistosoma mansoni to praziquantel: is there a problem? | Q35021630 |
| | Human schistosomiasis resistance to praziquantel in China: should we be worried? | Q35065595 |
| | The challenge of effective surveillance in moving from low transmission to elimination of schistosomiasis in China. | Q35327022 |
| | A diagnostic challenge for Schistosomiasis japonica in China: consequences on praziquantel-based morbidity control | Q35373854 |
| | The sensitivity of Schistosoma japonicum to praziquantel: a field evaluation in areas with low endemicity of China | Q35910564 |
| | Are Ca2+ channels targets of praziquantel action? | Q35993816 |
| | The public health significance and control of schistosomiasis in China--then and now. | Q36242180 |
| | Use of praziquantel for clinical treatment and morbidity control of schistosomiasis japonica in China: a review of 30 years' experience | Q36242185 |
| | Conquering schistosomiasis in China: the long march | Q36324372 |
| | Factors impacting on progress towards elimination of transmission of schistosomiasis japonica in China | Q36459859 |
| | New approaches for understanding mechanisms of drug resistance in schistosomes | Q37177725 |
| | Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis | Q37315241 |
| | China's new strategy to block Schistosoma japonicum transmission: experiences and impact beyond schistosomiasis | Q37605904 |
| | New insight into praziquantel against various developmental stages of schistosomes | Q37943763 |
| | Antimalarials in the treatment of schistosomiasis. | Q38011217 |
| | Susceptibility or resistance of praziquantel in human schistosomiasis: a review | Q38050973 |
| | Application of praziquantel in schistosomiasis japonica control strategies in China | Q38077463 |
| | Resistance to praziquantel: direct evidence from Schistosoma mansoni isolated from Egyptian villagers. | Q39096377 |
| | Characterization of isolates of Schistosoma mansoni from Egyptian villagers that tolerate high doses of praziquantel. | Q39096387 |
| | The efficacy of praziquantel against Schistosoma mansoni infection in Ndombo, northern Senegal | Q39515105 |
| | Failure of standard treatment with praziquantel in two returned travelers with Schistosoma haematobium infection | Q40486390 |
| | Chemistry of artemisinin: an overview | Q40684316 |
| | Is there reduced susceptibility to praziquantel in Schistosoma japonicum? Evidence from China | Q42920406 |
| | The sensitivity of artesunate against Schistosoma japonicum decreased after 10 years of use in China | Q43022710 |
| | A strategy to control transmission of Schistosoma japonicum in China | Q43367057 |
| | Susceptibility of Schistosoma japonicum to praziquantel in China | Q43736333 |
| | Efficacy of praziquantel against Schistosoma japonicum: field evaluation in an area with repeated chemotherapy compared with a newly identified endemic focus in Hunan, China | Q43798155 |
| | Schistosomiasis in China: acute infections during 2005-2008. | Q45174070 |
| | Therapeutic failure of praziquantel in the treatment of Schistosoma haematobium infection in Brazilians returning from Africa | Q46214180 |
| | Efficacy and Side Effects of Praziquantel in an Epidemic Focus of Schistosoma mansoni | Q46516480 |
| | A case of refractory schistosomiasis | Q46726739 |
| | Oxamniquine cures Schistosoma mansoni infection in a focus in which cure rates with praziquantel are unusually low. | Q46795013 |
| | Effects of the praziquantel-based control of schistosomiasis japonica in China | Q46889432 |
| | Schistosome resistance to praziquantel: Fact or artifact? | Q48568906 |
| | Is there a reduced sensitivity of dihydroartemisinin against praziquantel-resistant Schistosoma japonicum? | Q51191319 |
| | Schistosomiasis control: experiences and lessons from China. | Q51676769 |
| | Short report: diminished susceptibility to praziquantel in a Senegal isolate of Schistosoma mansoni. | Q54168883 |
| | Drug-resistant schistosomiasis: resistance to praziquantel and oxamniquine induced in Schistosoma mansoni in mice is drug specific. | Q54199827 |
| | The anthelmintic action of praziquantel | Q57219245 |
| | [Field studies on preventive effect of artemether against infection with Schistosoma japonicum] | Q70887673 |
| P433 | issue | 3 | |
| P921 | main subject | artemether | Q416199 |
| | praziquantel | Q424145 |
| | artesunate | Q707939 |
| | Schistosoma japonicum | Q1256989 |
| P304 | page(s) | 925-931 | |
| P577 | publication date | 2013-12-11 | |
| P1433 | published in | Parasitology Research | Q15755242 |
| P1476 | title | Efficacy of artemether and artesunate in mice infected with praziquantel non-susceptible isolate of Schistosoma japonicum | |
| P478 | volume | 113 | |